Elixir Products Investigations » Protocol of a four-month investigation of Elixir-11 used as an auxiliary means in patients suffering from tuberculosis
Protocol of a four-month investigation of Elixir-11 used as an auxiliary means in patients suffering from tuberculosis
The clinical examination started with 20 patients-volunteers suffering from pulmonary and non-pulmonary tuberculosis who were informed in advance about the clinical effects of this preparation. The patients were subjected to preliminary clinical examination and paraclinical analyses with respect to the hepatic and renal functions. They were also subjected to an obligatory X-ray control reflecting the specific manifestations of the tuberculous disease and the degree of damage on their organisms. The patients with non-pulmonary tuberculosis were subjected to echographic control of their abdominal organs.
Results
- After a four-month period, all patients in the control group (n=20) showed a considerable improvement of their status.
- All patients gained weight (from 3 to 8 kg). They manifested improved appetite and enhanced self-confidence.
- Sharp reduction of the asthenoadynamic syndrome, faster restoration of the general status in comparison with other patients in the stationary hospital who did not use Elixir-11.
- None of all 20 patients manifested aggravation or recurrence of acute tuberculosis.
- All patients did not discharge bacilli.
- Considerable resorption and reduction of rheomorphological changes were observed. None of the fluorograms made at the end of this investigation showed formations of caverns and destructions.
- Considerable reduction of the pain syndrome was observed in patients with osteoarthritic forms.
Conclusions
- Elixir-11, a herbal tincture made of leaves of Juglans regia L., fruits of Rosa canina L., flowers of Calendulal officinalis L., and flowers of Sambucus nigra L., shows a good organoleptic tolerance, good taste and easy assimilation by the patients.
- Elixir-11 had no side-effects of the sort of nephro- and hepatotoxicity.
- It did not develop additional allergies in disposed individuals.
- It acts to strengthen the organism in all forms of pulmonary tuberculosis, and there was no significant difference in its activity between pulmonary and other forms of tuberculosis.
- The basic therapeutic effect of Elixir-11 was to strengthen the organism and the protective mechanisms and to stimulate the appetite of the individual suffering from tuberculosis.
- Elixir 11 is equally well-applicable both independently and in combination with other tuberculostatics.
- Elixir-11 exerted effects both on patients with light form of tuberculosis and on persons with serious forms of this illness.
- No negative effects were recorded during the clinical investigation of Elixir-11.
- There were no any deviations in the hepatic and renal paraclinic parameters.
Rousse, November 15, 1996
Dr. Georgi Davidov, specialist in
the field of internal medicine and
pneumophthisiatria in the State pulmonary hospital in Rousse.